TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19468244

Group type: EXPERIMENTAL
Intervention: Akreos AO intraocular lens (IOL)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Akreos Adapt intraocular lens (IOL)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Akreos AO IOL
Number of subjects: 50

Group type: COMPARATOR
Intervention: Akreos Adapt IOL
Number of subjects: 50
Study: 16828533

Group type: EXPERIMENTAL
Intervention: Propranolol HCl administered before acquisition
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Propranolol HCl administered following extinction trials
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Conditioned stimuli were colored circles with a 'highly annoying' electrical stimulus as UCS
Number of subjects: 28

Group type: COMPARATOR
Intervention: Non-threat condition
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Threat condition
Number of subjects: 28
Study: 15272106

Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Paroxetine (selective serotonin reuptake inhibitor antidepressant)
Number of subjects: 52
Study: 11383378

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (1, 2.5, 5, 10, 20, 40, and 80 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9241125

Group type: EXPERIMENTAL
Intervention: Probucol (500 mg)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Combined treatment (Probucol + Multivitamins)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Multivitamins (30,000 IU beta carotene, 500 mg vitamin C, 700 IU vitamin E)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study: 8098339

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terfenadine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brompheniramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyproheptadine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clemastine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Astemizole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methacholine bronchoprovocation
Number of subjects: 0
Study: 2986562

Group type: EXPERIMENTAL
Intervention: Preoperative percutaneous transhepatic drainage (PTD)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Surgery without preoperative drainage
Number of subjects: 75
Study: 29956413

Group type: EXPERIMENTAL
Intervention: Stereotypical images
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Neutral images
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Counter-stereotypical images
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: No images
Number of subjects: 240
Study: 30567603

Group type: EXPERIMENTAL
Intervention: Twice-daily text-message reminders on case management of malaria
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Twice-daily text-message reminders on case management of malaria, pneumonia, and diarrhoea
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control arm (no text-message reminders)
Number of subjects: 50
Study: 27418212

Group type: EXPERIMENTAL
Intervention: Computerized antithrombotic risk assessment tool (CARAT)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 393
Study: 25058346

Group type: EXPERIMENTAL
Intervention: Nintedanib 150 mg BID plus standard dose of weekly paclitaxel
Number of subjects: 0
Study: 22434159

Group type: EXPERIMENTAL
Intervention: PCA with ISB
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: PCA with SSNB + ANB
Number of subjects: 61

Group type: COMPARATOR
Intervention: PCA only
Number of subjects: 61
Study: 20922265

Group type: EXPERIMENTAL
Intervention: Aerobic training program (walking three times a week for 13 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (educational lectures once a week)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Aerobic training program
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 17030077

Group type: EXPERIMENTAL
Intervention: Active/cooperative instruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional lecture-based instruction
Number of subjects: 0
Study: 18190273

Group type: EXPERIMENTAL
Intervention: Keepin' It Safe program
Number of subjects: 204

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 204
Study: 15207761

Group type: EXPERIMENTAL
Intervention: ibandronate therapy (6 or 12 mg)
Number of subjects: 20
Study: 10731544

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Standard support group
Number of subjects: 184

Group type: COMPARATOR
Intervention: Routine care control group
Number of subjects: 184
Study: 8957198

Group type: EXPERIMENTAL
Intervention: Broadband ultrasound attenuation in men (127.3 +/- 12.8 dB MHz-1)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Speed of sound in men
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Broadband ultrasound attenuation values in men
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Speed of sound values in men
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Speed of sound values in women
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Broadband ultrasound attenuation and speed of sound values in men
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Broadband ultrasound attenuation and speed of sound values in women
Number of subjects: 217
Study: 1306536

Group type: EXPERIMENTAL
Intervention: Isoglaucon (Clonidine hydrochloride) 15 microliters 0.125%
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Isoglaucon (Clonidine hydrochloride) 15 microliters 0.25%
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Isoglaucon (Clonidine hydrochloride) 15 microliters 0.50%
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Isoglaucon (Clonidine hydrochloride) 40 microliters 0.50%
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Isoglaucon (Clonidine hydrochloride) 40 microliters 0.125%
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Isoglaucon (Clonidine hydrochloride) 40 microliters 0.25%
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 2857361

Group type: EXPERIMENTAL
Intervention: 100% oxygen at 2 atmospheres absolute for 90 min daily for a total of 20 exposures
Number of subjects: 120

Group type: COMPARATOR
Intervention: Normal air at normal pressure for a similar length of time
Number of subjects: 120
Study: 31416741

Group type: EXPERIMENTAL
Intervention: NLP algorithm for identifying periprosthetic femur fractures (PPFFx)
Number of subjects: 4520

Group type: EXPERIMENTAL
Intervention: NLP algorithm for determining Vancouver classification of PPFFx
Number of subjects: 4520
Study: 27347862

Group type: EXPERIMENTAL
Intervention: Hip-focused muscle strengthening treatment program
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Knee-focused muscle strengthening treatment program
Number of subjects: 237

Group type: COMPARATOR
Intervention: All subjects (PFP and controls)
Number of subjects: 237
Study: 26121708

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 842

Group type: COMPARATOR
Intervention: Coronary artery bypass graft (CABG)
Number of subjects: 842
Study: 23615144

Group type: EXPERIMENTAL
Intervention: Negative beliefs about symptom management (SMBQ)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Perceived negative attitudes from healthcare providers (CommA)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Perceived communication difficulties (CommD)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 190
Study: 22032247

Group type: EXPERIMENTAL
Intervention: EBQI applied to CCM implementation
Number of subjects: 546

Group type: COMPARATOR
Intervention: Usual care (non-CCM)
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: PCC predilection to adopt CCM
Number of subjects: 546
Study: 18814197

Group type: EXPERIMENTAL
Intervention: Caregiver education and training intervention delivered over five, weekly, half‐hour sessions consisting of assessment, basic education about dementia, and training regarding specific problem behaviors.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medical care as usual (Control group)
Number of subjects: 60
Study: 16484875

Group type: EXPERIMENTAL
Intervention: Rofecoxib 12.5 mg per day
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Nabumetone 500 mg twice a day
Number of subjects: 978

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 978
Study: 12941090

Group type: EXPERIMENTAL
Intervention: 2% hydroquinone‐cyclodextrin formulation applied once daily for 2 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (untreated forearm)
Number of subjects: 30
Study: 10711913

Group type: EXPERIMENTAL
Intervention: Lamotrigine (300 mg by mouth)
Number of subjects: 16
Study: 9180438

Group type: EXPERIMENTAL
Intervention: Continuous cardiac output (CCO) monitoring
Number of subjects: 38
Study: 1609592

Group type: EXPERIMENTAL
Intervention: Dynamic Hip screws
Number of subjects: 73

Group type: COMPARATOR
Intervention: Gouffon screws
Number of subjects: 73
Study: 3908046

Group type: EXPERIMENTAL
Intervention: Active alveolar expansion using an incentive spirometer
Number of subjects: 30
Study: 31246555

Group type: EXPERIMENTAL
Intervention: Rhythmic handgrip (RHG; 1:1 duty cycle, 40% maximal voluntary contraction)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: One-leg cycling (17 ± 3% peak power output)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Concurrent exercise at the same intensities as RHG and cycling
Number of subjects: 35
Study: 29982253

Group type: EXPERIMENTAL
Intervention: EA-230
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 27008287

Group type: COMPARATOR
Intervention: C-arm guided epidural injection of local anesthetic and corticosteroid
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 50 international unit calcitonin added to the mixture of local anesthetic and corticosteroid
Number of subjects: 132
Study: 24882173

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Post-hoc analysis
Number of subjects: 79
Study: 22444945

Group type: EXPERIMENTAL
Intervention: DQIP intervention (web-based informatics tool, outreach visit, fixed payment, and per patient review payment)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: DQIP intervention
Number of subjects: 40
Study: 20060081

Group type: EXPERIMENTAL
Intervention: Teriparatide (20 mug/day)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Alendronate (10 mg/day)
Number of subjects: 157
Study: 17366252

Group type: EXPERIMENTAL
Intervention: Behavioral interventions
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: More outreach contacts
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Not being homeless
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Fewer problems with alcohol
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: More problems with drugs
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Contemplation or determination stage of change
Number of subjects: 491
Study: 16085693

Group type: EXPERIMENTAL
Intervention: Ghrelin (5 pmol/kg/min)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 10
Study: 11600532

Group type: EXPERIMENTAL
Intervention: Melatonin 0.3 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Melatonin 3.0 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Melatonin 0.1 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 9875064

Group type: EXPERIMENTAL
Intervention: Partially hydrogenated fish oil (PHFO) margarine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vegetable oil (VO) margarine
Number of subjects: 16
Study: 8021413

Group type: EXPERIMENTAL
Intervention: Squeezable cleft palate nurser
Number of subjects: 31

Group type: COMPARATOR
Intervention: Crosscut nipple
Number of subjects: 31
Study: 2723107

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 8
Study: 31808657

Group type: EXPERIMENTAL
Intervention: Intraoperative acupuncture (AC)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Standard anesthesia care (SC)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Overall comparison of AC vs SC
Number of subjects: 99
Study: 30374965

Group type: EXPERIMENTAL
Intervention: Liraglutide treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28592571

Group type: EXPERIMENTAL
Intervention: Full internet-based aural rehabilitation (n=37)
Number of subjects: 74

Group type: COMPARATOR
Intervention: One element of the internet-based aural rehabilitation (control group, n=37)
Number of subjects: 74
Study: 25003623

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (individual home exercise program) for 12 weeks
Number of subjects: 122
Study: 22949577

Group type: EXPERIMENTAL
Intervention: osmotic‐release oral system methylphenidate (OROS‐MPH) + transdermal nicotine replacement + brief cessation counseling
Number of subjects: 255

Group type: COMPARATOR
Intervention: placebo + transdermal nicotine replacement + brief cessation counseling
Number of subjects: 255
Study: 21939534

Group type: EXPERIMENTAL
Intervention: Convergent proximal pin placement (Group A)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Parallel proximal pin placement (Group B)
Number of subjects: 70
Study: 18791983

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group psychotherapy in combination with open methylphenidate treatment (Medikinet retard ®) titrated upward individually until the maximum dose of 1.3 mg/kg/day
Number of subjects: 144

Group type: COMPARATOR
Intervention: Supportive counselling
Number of subjects: 144
Study: 16548956

Group type: EXPERIMENTAL
Intervention: Diclofenac‐Hand group (diclofenac transdermal patch on the dorsum of hand and placebo patch on the buttock)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Diclofenac‐Buttock group (placebo patch on the dorsum of the hand and diclofenac transdermal patch on the buttock)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (placebo adhesive patch on both the dorsum of hand and the buttock)
Number of subjects: 72
Study: 14641393

Group type: EXPERIMENTAL
Intervention: Home visit and booklet education
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 120
Study: 11060685

Group type: EXPERIMENTAL
Intervention: β-blocker therapy
Number of subjects: 0
Study: 9040687

Group type: EXPERIMENTAL
Intervention: Internal carotid peak systolic velocity (IPSV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internal carotid end‐diastolic velocity (IEDV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IPSV/CEDV ratio
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Common carotid peak systolic velocity (CPSV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ratios of IPSV/CEDV and IEDV/CEDV
Number of subjects: 0
Study: 7717053

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no ketorolac tromethamine)
Number of subjects: 50
Study: 2908720

Group type: EXPERIMENTAL
Intervention: celiprolol 400 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: enalapril 20 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 30787294

Group type: EXPERIMENTAL
Intervention: RV144 HIV vaccine
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study: 30089018

Group type: EXPERIMENTAL
Intervention: Bingocize® (Bingo + Health Education + Exercise)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (Bingo + Health Education)
Number of subjects: 100
Study: 27468593

Group type: EXPERIMENTAL
Intervention: Benzocaine (5%)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ketoprofen (1.60 mg/mL)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 20
Study: 25245482

Group type: EXPERIMENTAL
Intervention: Traditional Swallowing (TS) therapy
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Combined NMES/TS therapy
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Oropharyngeal neuromuscular electrical stimulation (NMES) therapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 29
Study: 22989795

Group type: EXPERIMENTAL
Intervention: Treatment group (n=81)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Control group (n=43)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Best Standard of Care (BSC) group (n=137)
Number of subjects: 261
Study: 19296100

Group type: EXPERIMENTAL
Intervention: MACT of the ankle joint
Number of subjects: 22
Study: 17265406

Group type: EXPERIMENTAL
Intervention: Treatment for bacterial pneumonia (specifics not provided)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hospital's pneumonia care plan (not specified)
Number of subjects: 0
Study: 15041701

Group type: EXPERIMENTAL
Intervention: 25000 IU/day vitamin A
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: 50000 IU/day vitamin A
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: 75000 IU/day vitamin A
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 12428086

Group type: EXPERIMENTAL
Intervention: DX-9065a (1 mg bolus + 0.25 mg/h x 2 h, followed by 1 mg bolus + 0.625 mg/h x 2 h, and a final 1 mg bolus + 1.25 mg/h x 2 h)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: DX-9065a + ASA (pre-treatment)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Enoxaparin + ASA (1 mg/Kg s. c + 162 mg/day x 3 days)
Number of subjects: 6
Study: 9454525

Group type: EXPERIMENTAL
Intervention: Troglitazone 400 mg/d
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Troglitazone 600 mg/d
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Troglitazone 200 mg/d
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 8578993

Group type: EXPERIMENTAL
Intervention: Caffeine (Cf, 50 mg/g of ointment or solution)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Interferon (IFN, 5 x 10(4) IU/g)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Mixture of Caffeine and Interferon (same concentrations)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 2236825

Group type: EXPERIMENTAL
Intervention: beta-lactam and aminoglycoside
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: vancomycin (added after 48 hours)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: amphotericin B (added after 96 hours)
Number of subjects: 102
Study: 365543

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Methyldopa
Number of subjects: 20
Study: 7237896

Group type: EXPERIMENTAL
Intervention: Ticrynafen (TCNF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol with either diuretic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 0
Study: 31155431

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Expiratory muscle training
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (fixed resistance expiratory muscle training)
Number of subjects: 31
Study: 31507249

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 143

Group type: COMPARATOR
Intervention: Other medications for gout treatment
Number of subjects: 143

Group type: COMPARATOR
Intervention: Healthy individuals
Number of subjects: 143

Group type: COMPARATOR
Intervention: Untreated gout patients
Number of subjects: 143
Study: 27260298

Group type: EXPERIMENTAL
Intervention: PriMa intervention group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 26274840

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation
Number of subjects: 19
Study: 24370353

Group type: EXPERIMENTAL
Intervention: FOLFOX4 with cetuximab
Number of subjects: 302

Group type: COMPARATOR
Intervention: UFOX with cetuximab
Number of subjects: 302
Study: 21776573

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Alfacalcidol
Number of subjects: 60

Group type: COMPARATOR
Intervention: No medication
Number of subjects: 60
Study: 19159947

Group type: EXPERIMENTAL
Intervention: Cinnamon supplementation (3 g day(‐1))
Number of subjects: 8
Study: 17517346

Group type: EXPERIMENTAL
Intervention: Pacing at 60 ppm
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Pacing at 75 ppm
Number of subjects: 13

Group type: COMPARATOR
Intervention: Pacing at 90 ppm
Number of subjects: 13
Study: 15447908

Group type: EXPERIMENTAL
Intervention: Fortified spread (FS)
Number of subjects: 374

Group type: COMPARATOR
Intervention: Unfortified spread (US)
Number of subjects: 374

Group type: COMPARATOR
Intervention: Control
Number of subjects: 374
Study: 12151917

Group type: EXPERIMENTAL
Intervention: Parecoxib sodium 20 mg
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Parecoxib sodium 40 mg
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg
Number of subjects: 202

Group type: COMPARATOR
Intervention: Intravenous morphine 4 mg
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 10409961

Group type: EXPERIMENTAL
Intervention: Kit A (System 4)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Kit B (Charing Cross)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Kit C (Profore)
Number of subjects: 57
Study: 7792125

Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil (8 mg/kg/day twice daily)
Number of subjects: 1188

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanic acid
Number of subjects: 1188

Group type: COMPARATOR
Intervention: Cefaclor
Number of subjects: 1188

Group type: COMPARATOR
Intervention: Cefixime
Number of subjects: 1188
Study: 2284602

Group type: EXPERIMENTAL
Intervention: Peer telephone network
Number of subjects: 0

Group type: COMPARATOR
Intervention: Informational lecture series accessed over the telephone
Number of subjects: 0